Furthermore, miat downregulation promoted the progression of senescence and activated the tumor suppressor pathway p53/p21 and p16/pRb, which promoted the production of SASP and contributed to tumor cell proliferation inhibition, resulting in inhibition of HCC tumorigenesis. This evidence concerns the gene MIAT and hepatocellular carcinoma.